Silverback Therapeutics shares owned by Summit Investment Advisors
Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Summit Investment Advisors
from 13F filings
Historical chart of Summit Investment Advisors investment in Silverback Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Silverback Therapeutics held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Silverback Therapeutics by Summit Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $51k | 4.8k | 10.55 |
| 2024-09-30 | $70k | 4.8k | 14.50 |
| 2024-06-30 | $41k | 4.8k | 8.51 |
| 2024-03-31 | $21k | 2.0k | 10.22 |
| 2023-12-31 | $11k | 2.0k | 5.48 |
| 2023-09-30 | $7.6k | 2.0k | 3.78 |
| 2023-06-30 | $13k | 2.0k | 6.70 |
| 2022-03-31 | $4.0k | 1.0k | 3.88 |
| 2021-12-31 | $7.0k | 1.0k | 6.78 |
| 2021-09-30 | $10k | 1.0k | 9.69 |
| 2021-06-30 | $32k | 1.0k | 31.01 |
| 2021-03-31 | $45k | 1.0k | 43.60 |
More positions owned by Summit Investment Advisors
View all positions for Summit Investment Advisors